Perpetually Adaptive Enterprise
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
- Banking
- Capital Markets
- Consumer Packaged Goods and Distribution
- Communications, Media, and Information Services
- Education
- Energy, Resources, and Utilities
- Healthcare
- High Tech
- Insurance
- Life Sciences
- Manufacturing
- Public Services
- Retail
- Travel and Logistics
- Artificial Intelligence and Data & Analytics
- Cloud
- Cognitive Business Operations
- Consulting
- Cybersecurity
- Enterprise Solutions
- IoT and Digital Engineering
- Network Solutions and Services
- Sustainability Services
- TCS Interactive
Perpetually Adaptive Enterprise
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
About Us
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
TCS Insights
Point of views, research, studies - on the latest themes - to help you expand your knowledge and be future ready.
Upcoming events
02 Dec 2025
TCS BaNCS at BankenTech 2025 Frankfurt
01 Dec 2025
TCS at AWS re:Invent 2025
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Want to be a global change-maker? Join our team.
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?
Products and Platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
Join the TCS ADD™ forum at Pace Port™ London to explore AI/generative AI in clinical R&D and pharmacovigilance and how it is transforming life sciences.
Events
22 Sep 2025
Explore how leveraging AI and generative AI in medical research can streamline literature reviews, access databases, and improve clinical decision-making.
Article
26 Nov 2025
AI in pharmacovigilance enhances automated data processing, improves AEs detection accuracy, and ensures patient safety in life sciences. Discover more.
White Paper
13 Nov 2025
Smart bio research
Medical research today is growing at an unprecedented pace, with millions of new articles published every year and vast repositories like PubMed hosting tens of millions of abstracts. For researchers and healthcare professionals, this abundance of information is both a blessing and a challenge. Finding the right studies, extracting meaningful insights, and validating safety data often feels like searching for a needle in a haystack. Traditional methods rely heavily on manual review, which is slow, repetitive, and prone to error. These inefficiencies create significant bottlenecks in drug development, clinical trials, and regulatory compliance, where timely decisions can have a direct impact on patient safety.
The whitepaper explores how AI and Gen AI can transform this process. By leveraging advanced large language models trained on biomedical data, the proposed solution automates literature reviews, summarises research papers, and extracts key findings with remarkable accuracy. Instead of spending hours reading and cross-referencing, researchers can now pose natural language queries and receive context-aware responses. The system integrates APIs from PubMed Central for article retrieval and uses BioC for structured text extraction. For handling multiple documents, it utilises a vector database that stores content as embeddings, allowing for semantic search and linking related research findings. This architecture ensures scalability and speed, turning raw data into actionable insights.
AI for drug safety
One of the most impactful applications is in pharmacovigilance, where safety signal detection is critical. The AI-driven workflow classifies literature into valid Individual Case Safety Reports (ICSRs), potential ICSRs, and non-ICSRs, thereby reducing manual intervention while maintaining accuracy and precision. This not only accelerates compliance processes but also strengthens drug safety monitoring.
The benefits are clear: review times are drastically reduced, precision is enhanced through semantic understanding, and scalability enables the simultaneous processing of thousands of articles. These improvements support essential functions like clinical trial design, post-market surveillance, and regulatory policymaking. As the healthcare analytics and life sciences markets continue to grow rapidly, such solutions are becoming indispensable.
Beyond literature
Looking ahead, the approach can be extended across domains, incorporating real-time literature analysis and more advanced contextual AI capabilities. The integration of AI and GenAI in medical research is not just a technological advancement; it is a necessity for keeping pace with the ever-expanding body of scientific knowledge. By addressing inefficiencies and reducing costs, these innovations ensure timely access to accurate insights, ultimately improving patient safety and accelerating clinical research.
The white paper was presented at PharmaSUG 2025 in the U.S., showcasing how AI and gen AI revolutionise medical literature review, accelerating insights and improving drug safety.
Dive deeper into the insights! Click here to explore the full PharmaSUG 2025 paper and uncover the complete context behind this excerpt.
Related reading
Swipe Left
Swipe Right
Transformation starts here
Learn how we can help you bring drugs to the market faster.
Talk to our experts